AF
GSK icon

Allworth Financial’s GSK GSK Stock Holding History

Allworth Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530K Sell
10,110
-3,186
-24% -$168K ﹤0.01% 958
2026
Q1 		$734K Buy
13,296
+2,058
+18% +$112K ﹤0.01% 809
2025
Q4 		$551K Buy
11,238
+1,865
+20% +$87K ﹤0.01% 891
2025
Q3 		$405K Buy
9,373
+447
+5% +$17.5K ﹤0.01% 969
2025
Q2 		$343K Buy
8,926
+1,222
+16% +$46.7K ﹤0.01% 961
2025
Q1 		$289K Sell
7,704
-155
-2% -$5.67K ﹤0.01% 840
2024
Q4 		$263K Buy
7,859
+5,001
+175% +$180K ﹤0.01% 863
2024
Q3 		$117K Sell
2,858
-414
-13% -$16.9K ﹤0.01% 1018
2024
Q2 		$129K Buy
3,272
+553
+20% +$23.3K ﹤0.01% 975
2024
Q1 		$117K Buy
2,719
+150
+6% +$6.19K ﹤0.01% 961
2023
Q4 		$95.2K Buy
2,569
+96
+4% +$3.45K ﹤0.01% 962
2023
Q3 		$89.7K Sell
2,473
-243
-9% -$8.63K ﹤0.01% 920
2023
Q2 		$96.8K Sell
2,716
-152
-5% -$5.45K ﹤0.01% 909
2023
Q1 		$102K Buy
2,868
+632
+28% +$22.1K ﹤0.01% 853
2022
Q4 		$78.6K Buy
2,236
+401
+22% +$13.4K ﹤0.01% 877
2022
Q3 		$54K Buy
1,835
+67
+4% +$2.54K ﹤0.01% 932
2022
Q2 		$96K Buy
1,768
+782
+79% +$43.2K ﹤0.01% 726
2022
Q1 		$54K Buy
986
+268
+37% +$14.6K ﹤0.01% 860
2021
Q4 		$40K Buy
718
+52
+8% +$2.71K ﹤0.01% 898
2021
Q3 		$32K Hold
666
– – ﹤0.01% 899
2021
Q2 		$33K Sell
666
-7
-1% -$336 ﹤0.01% 719
2021
Q1 		$30K Hold
673
– – ﹤0.01% 682
2020
Q4 		$31K Buy
673
+1
+0.1% +$46 ﹤0.01% 566
2020
Q3 		$32K Buy
672
+20
+3% +$1K ﹤0.01% 492
2020
Q2 		$33K Buy
652
+1
+0.2% +$51 ﹤0.01% 484
2020
Q1 		$31K Buy
651
+8
+1% +$427 ﹤0.01% 484
2019
Q4 		$38K Sell
643
-415
-39% -$23.1K ﹤0.01% 410
2019
Q3 		$56K Sell
1,058
-48
-4% -$2.47K ﹤0.01% 307
2019
Q2 		$55K Buy
1,106
+415
+60% +$20.8K ﹤0.01% 309
2019
Q1 		$36K Buy
691
+122
+21% +$6.1K ﹤0.01% 365
2018
Q4 		$27K Sell
569
-69
-11% -$3.4K ﹤0.01% 364
2018
Q3 		$32K Buy
638
+42
+7% +$2.13K ﹤0.01% 352
2018
Q2 		$30K Buy
596
+162
+37% +$8.16K ﹤0.01% 346
2018
Q1 		$21K Buy
434
+12
+3% +$559 ﹤0.01% 369
2017
Q4 		$19K Sell
422
-5
-1% -$231 ﹤0.01% 383
2017
Q3 		$22K Buy
427
+102
+31% +$5.17K ﹤0.01% 349
2017
Q2 		$18K Buy
325
+114
+54% +$6.08K ﹤0.01% 391
2017
Q1 		$11K Buy
211
+46
+28% +$2.33K ﹤0.01% 433
2016
Q4 		$8K Hold
165
– – ﹤0.01% 418
2016
Q3 		$9K Buy
165
+49
+42% +$2.69K ﹤0.01% 426
2016
Q2 		$6K Hold
116
– – ﹤0.01% 433
2016
Q1 		$6K Buy
116
+48
+71% +$2.39K ﹤0.01% 426
2015
Q4 		$3K Sell
68
-1,028
-94% -$52.4K ﹤0.01% 500
2015
Q3 		$53K Hold
1,096
– – 0.02% 206
2015
Q2 		$57K Hold
1,096
– – 0.02% 200
2015
Q1 		$63K Buy
+1,096
New +$62.8K 0.02% 186

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Allworth Financial's GSK Position: Q2 2026 in Review

Allworth Financial reduced its GSK (GSK) stake by 24% in Q2 2026, selling an estimated $168K and leaving 10,110 shares worth $530K. The position accounts for ﹤0.01% of the portfolio, ranked #958.

Allworth Financial first reported a position in GSK in Q1 2015 and has held it in 46 quarters since. The position peaked at $734K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Allworth Financial held 10,110 shares of GSK worth $530K as of Q2 2026.
  • Allworth Financial sold 3,186 GSK shares in Q2 2026, an estimated $168K.
  • GSK made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #958 holding.
  • Allworth Financial first reported a position in GSK in Q1 2015 and has held it in 46 quarters since.
  • Allworth Financial's GSK position peaked at $734K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.